Abstract
Type 2 diabetes (T2D) is a recognized risk factor for developing cataract. However, it is unclear if the shared genetic variance and potential genetic causal relationship between T2D and cataract are different for males and females. We evaluated sex-specific genetic correlation (rg) and putative genetic causality between the two diseases by using linkage disequilibrium score regression (LDSC) and six Mendelian randomization (MR) approaches after leveraging large-scale population-based genome-wide association studies (GWAS) summary of T2D and cataract. Application of LDSC found a significant genetic correlation between T2D and cataract in East Asian males (rg=0.68, 95% confident interval [CI]=0.17 to 1, p-value=8.60×10−3) but a non-significant genetic correlation in East Asian females (rg=0.25, CI= -0.02 to 0.52, p-value=8.38×10−2). MR analyses indicated a consistently stronger (paired t-test |t|=5.87, p-value=2.04×10−3) causal effect of T2D on cataract in East Asian males (liability OR=1.20 to 1.41, p-value=5.86×10−27 to 6.60×10−6) than in females (liability OR=1.12 to 1.21, p-value=2.02×10−14 to 1.82×10−2). In Europeans, the LDSC analysis suggested a close significant genetic correlation between the two diseases in males (rg=0.20, 95% confident interval [CI]=0.08 to 0.32, p-value=7.00×10−4) and females (rg=0.17, CI= 0.05 to 0.29, p-value=4.90×10−3); but the MR analyses provided weak evidences on a causal relationship between the two diseases in both sexes. These results presented the first evidence on sex difference of the casual relationship between cataract and T2D in East Asians, and supported a potential genetic heterogeneity of the shared genetics underlying T2D and cataract between East Asians and Europeans in both sexes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work was partly funded by the National Key R&D Program of China (2020YFB0204803; YD.Y, Sun Yat-sen University), the Natural Science Foundation of China (81801132, and 81971190; HY.Zhao, Sun Yat-sen Memorial Hospital; 61772566, 62041209, and U1611261; YD.Y, Sun Yat-sen University), Guangdong Key Field R&D Plan (2019B020228001 and 2018B010109006; YD.Y, Sun Yat-sen University), Introducing Innovative and Entrepreneurial Teams (2016ZT06D211, YD.Y, Sun Yat-sen University), Guangzhou S&T Re-search Plan (202007030010, YD.Y, Sun Yat-sen University), and Mater Foundation (YH.Y, Mater Research).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The BBJ project was approved by research ethics committees at the Institute of Medical Science, the University of Tokyo, the RIKEN Yokohama Institute, and the 12 cooperating hospitals. The UK Biobank project was approved by the North West Multi-center Research Ethics Committee. The 22 sub cohorts used in AGEN-T2D GWAS were approved by relevant institutions.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.